var data={"title":"Pleural effusions in HIV-infected patients","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Pleural effusions in HIV-infected patients</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/contributors\" class=\"contributor contributor_credentials\">Jose Joseph-Vempilly, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/contributors\" class=\"contributor contributor_credentials\">John G Bartlett, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/contributors\" class=\"contributor contributor_credentials\">V Courtney Broaddus, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/contributors\" class=\"contributor contributor_credentials\">Geraldine Finlay, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 21, 2017.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural effusions are frequently encountered in patients with acquired immunodeficiency syndrome (AIDS). The prevalence of pleural effusion in hospitalized patients with AIDS varies from 7 to 27 percent [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1-3\" class=\"abstract_t\">1-3</a>]. The variations in prevalence may be explained by differences in the clinical stage of AIDS and the techniques used in detecting pleural effusion.</p><p>The majority of pleural effusions in patients with HIV infection are caused by infections; however, about a third are due to noninfectious causes [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2\" class=\"abstract_t\">2</a>]. Now that viral infections appear responsible for some of the malignant effusions (eg, Kaposi sarcoma, multicentric Castleman's disease, primary effusion lymphoma), the line between infectious and noninfectious causes is blurred. In addition, much of the data regarding prevalence come from hospitalized patients with advanced HIV infection in the pre-potent antiretroviral therapy (ART) era and may not reflect the post-potent ART experience.</p><p>The etiology of the pleural effusion can be established in the majority of patients with AIDS, although a small percentage remains undiagnosed, as is the case in the non-AIDS population [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2\" class=\"abstract_t\">2</a>]. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;</a>.)</p><p>The common causes of pleural effusions in patients with HIV infection are reviewed here. The general approach to the investigation of a pleural effusion is discussed separately. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">&quot;Diagnostic evaluation of a pleural effusion in adults: Initial testing&quot;</a> and <a href=\"topic.htm?path=ultrasound-guided-thoracentesis\" class=\"medical medical_review\">&quot;Ultrasound-guided thoracentesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">INFECTIOUS CAUSES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In patients with HIV infection, many of the same infectious agents that cause pneumonia should be considered as potential etiologies of pleural effusion (<a href=\"image.htm?imageKey=PULM%2F58777%7EPULM%2F71626\" class=\"graphic graphic_table graphicRef58777 graphicRef71626 \">table 1A-B</a>). Among studies of hospitalized patients with a pleural effusion and HIV infection, an infectious etiology was identified in about two-thirds [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1-3\" class=\"abstract_t\">1-3</a>]. In general, opportunistic infections of the pleura should be considered in patients with a CD4 count below 150 cells per microL, as these patients have an increased risk of opportunistic infection, possibly approaching that of pre-potent antiretroviral therapy (ART) patients.</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h2\">Bacterial pneumonia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Bacterial pneumonia was the most common cause of pleural effusion in acquired immunodeficiency syndrome (AIDS), accounting for approximately 30 percent of effusions in three series of hospitalized patients with AIDS in the pre-potent antiretroviral therapy (ART) era [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1-3\" class=\"abstract_t\">1-3</a>]. In a series of 137 patients with community-acquired pneumonia, HIV-infected patients had a higher rate of parapneumonic effusions than non-HIV-infected patients [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/4\" class=\"abstract_t\">4</a>]. With the introduction of potent ART, the incidence of bacterial pneumonia [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/5\" class=\"abstract_t\">5</a>] and the complication of parapneumonic effusion have decreased in HIV infected patients [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/6\" class=\"abstract_t\">6</a>].</p><p>Most of these parapneumonic effusions are small and ipsilateral to the side of the pneumonia. The fluid is exudative and generally nucleated cell counts are low [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2\" class=\"abstract_t\">2</a>]. Empyema is common and, compared to immunocompetent patients, staphylococci were significantly more often isolated from pleural fluid culture in patients with AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/4,7\" class=\"abstract_t\">4,7</a>].</p><p>Streptococcus pneumoniae accounts for more than 50 percent of these parapneumonic effusions; Staphylococcus aureus is the next most common etiologic organism. Less frequent causes include Haemophilus influenzae, Mycoplasma pneumoniae, Legionella, Nocardia asteroides, and Bordetella bronchiseptica [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2,8\" class=\"abstract_t\">2,8</a>]. Septic pulmonary embolization from right-sided endocarditis in intravenous drug abusers can also result in small pleural effusions.</p><p>Treatment of bacterial pneumonia in HIV-infected patients is discussed separately. Uncomplicated parapneumonic effusions generally resolve with treatment of the underlying pneumonia. (See <a href=\"topic.htm?path=bacterial-pulmonary-infections-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Bacterial pulmonary infections in HIV-infected patients&quot;</a> and <a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">&quot;Parapneumonic effusion and empyema in adults&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Pneumocystis jirovecii</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pneumocystis jirovecii pneumonia (PCP) remains an uncommon cause of pleural effusion in HIV-infected patients, with an incidence varying from 3 to 15 percent in hospitalized patients [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Based on a small case series, there is a suggestion that pleural effusion due to PCP is more common in patients receiving aerosolized <a href=\"topic.htm?path=pentamidine-drug-information\" class=\"drug drug_general\">pentamidine</a> prophylaxis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/9\" class=\"abstract_t\">9</a>]. In addition to pleural effusion [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/10-12\" class=\"abstract_t\">10-12</a>], PCP also is associated with pleural masses and pneumothorax [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1,13-15\" class=\"abstract_t\">1,13-15</a>].</p><p>Pleural effusions due to PCP are usually small to moderate in size; can be either unilateral or bilateral; and are serous to bloody in appearance. Pleural fluid acidosis (ie, pH &lt;7.20) has not been reported. Lactic dehydrogenase (LDH) is elevated, with a pleural fluid to serum ratio greater than 1, characterizing the fluid as an exudate. Total protein pleural fluid to serum ratio tends to be less than 0.5, and pleural fluid glucose and amylase are equivalent to serum values [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/9\" class=\"abstract_t\">9</a>]. The total nucleated cell count is low, and the differential shows predominantly mononuclear cells.</p><p>A definitive diagnosis requires demonstration of the trophozoite or cyst forms of Pneumocystis in the pleural fluid. Grocott silver staining will show the cysts; however, if the pleural fluid has predominantly trophozoite forms, silver stain may not be sufficiently sensitive to establish the diagnosis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/10\" class=\"abstract_t\">10</a>]. In such cases, examination of an air-dried Diff-Quik stained cytospin preparation is ideal [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/11\" class=\"abstract_t\">11</a>].</p><p>Other markers of Pneumocystis pleural infection are the presence of granular eosinophilic aggregates, numerous vacuolated macrophages, and scattered benign mesothelial cell clusters in the pleural fluid. The diagnosis of pleural effusion due to Pneumocystis can be made presumptively if the organisms are identified in bronchoalveolar lavage (BAL) fluid and the effusion resolves following treatment for PCP. (See <a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-pneumocystis-pulmonary-infection-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Clinical presentation and diagnosis of Pneumocystis pulmonary infection in HIV-infected patients&quot;</a>.)</p><p>Neither the treatment nor the prognosis of PCP is altered by the development of a pleural effusion. On the other hand, the development of pneumothorax in these patients is often an ominous occurrence, and usually signals the need for prolonged chest tube drainage.</p><p>The treatment of P. jirovecii in HIV-infected patients is reviewed separately. (See <a href=\"topic.htm?path=treatment-and-prevention-of-pneumocystis-infection-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Treatment and prevention of Pneumocystis infection in HIV-infected patients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Mycobacteria</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Mycobacterial infection accounts for 8 to 10 percent of pleural effusions in patients with AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1,2\" class=\"abstract_t\">1,2</a>]. In most series, Mycobacterium tuberculosis (TB) was found to cause pleuritis more often than Mycobacterium avium complex (MAC); however, one study of 130 patients found the opposite in that 6 percent of HIV related effusions were due to MAC and 1 percent to TB [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2,3,6,16\" class=\"abstract_t\">2,3,6,16</a>]. Other nontuberculous mycobacteria rarely cause pleural disease [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/17\" class=\"abstract_t\">17</a>]. A discussion of the diagnosis and treatment of tuberculous pleurisy in HIV-infected patients is provided separately. (See <a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">&quot;Tuberculous pleural effusion&quot;</a>.)</p><p>Pleural TB may be present with or without visible lung parenchymal disease. In a series of 70 patients with HIV infection and pleural TB, the chest radiograph showed an isolated pleural effusion, associated pulmonary parenchymal infiltrate, and a miliary pattern in 51, 37, and 8 percent, respectively [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/18\" class=\"abstract_t\">18</a>]. In a case report, a pleural effusion due to MAC infection was large enough to cause hemodynamic compromise [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/19\" class=\"abstract_t\">19</a>]. </p><p>The pleural effusion is virtually always exudative and usually demonstrates neither pleural fluid acidosis nor low glucose levels [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/20\" class=\"abstract_t\">20</a>]. The nucleated cell counts in the pleural fluid are lower than those seen in TB pleurisy of HIV-uninfected patients; a predominance of lymphocytes is usually noted. Pleural fluid lymphocytes and CD14 positive macrophages have been shown to be a sanctuary for increased HIV replication in patients with Mycobacterium tuberculosis pleurisy [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/21\" class=\"abstract_t\">21</a>]. Molecular testing for Mycobacterium <span class=\"nowrap\">tuberculosis/resistance</span> to rifampicin <span class=\"nowrap\">(MTB/RIF)</span> assay has some value for rapid (ie, within two hours) diagnosis of pleural tuberculosis, especially when performed on pleural tissue. However, the routine use of this assay is not recommended in pleural fluid due to its low diagnostic sensitivity (approximately 45 percent) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/22-25\" class=\"abstract_t\">22-25</a>]. </p><p>Other diagnostic tests include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The <a href=\"topic.htm?path=tuberculin-skin-test-drug-information\" class=\"drug drug_general\">tuberculin skin test</a> (PPD) is positive in 20 to 64 percent of patients [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/18,26\" class=\"abstract_t\">18,26</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural fluid adenosine deaminase (ADA) is typically greater than 50 <span class=\"nowrap\">U/L</span> in tuberculous pleural effusions, independent of HIV status [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/27\" class=\"abstract_t\">27</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sputum acid-fast smear is positive more often in HIV-infected patients with advanced immunodeficiency compared to those with relatively preserved CD4 cell counts [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/18,26\" class=\"abstract_t\">18,26</a>]. Sputum induction may be helpful [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/28\" class=\"abstract_t\">28</a>].</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pleural fluid acid-fast smear is positive in less than 15 percent of tuberculous effusions.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural biopsy for acid-fast stain and pathologic examination for granulomas is helpful with yields better than 50 percent [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/18,20\" class=\"abstract_t\">18,20</a>].</p><p/><p>The treatment of TB in HIV-infected patients is discussed separately. (See <a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">&quot;Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy&quot;</a>.)</p><p>Immune reconstitution inflammatory syndrome (IRIS) refers to paradoxical worsening of systemic inflammation associated with preexisting infectious processes following the initiation of ART in HIV-infected individuals [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/29\" class=\"abstract_t\">29</a>]. This is more likely in patients with a CD4 count under 100 cells per microL and in the setting of initiation of TB treatment [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/29,30\" class=\"abstract_t\">29,30</a>]. Patients may present with worsening constitutional symptoms, pulmonary parenchymal disease, adenopathy, or pleural effusion [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/30,31\" class=\"abstract_t\">30,31</a>]. (See <a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome\" class=\"medical medical_review\">&quot;Immune reconstitution inflammatory syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Nocardia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Nocardia asteroides has been identified in about 3 percent of pleural effusions in patients with AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2,32,33\" class=\"abstract_t\">2,32,33</a>]. It is generally associated with more advanced AIDS. The evaluation and treatment of nocardia are discussed separately. (See <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-nocardiosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of nocardiosis&quot;</a> and <a href=\"topic.htm?path=treatment-of-nocardiosis\" class=\"medical medical_review\">&quot;Treatment of nocardiosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Cryptococcus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Cryptococcus neoformans can occasionally cause pleural effusions in patients with AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/34\" class=\"abstract_t\">34</a>]. In AIDS patients, an isolated pleural effusion may be the initial manifestation of disseminated cryptococcal disease in AIDS, whereas, in non-AIDS patients, an effusion is usually seen in association with pulmonary parenchymal disease [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2,35-38\" class=\"abstract_t\">2,35-38</a>]. C. laurentii, another strain of cryptococcus, has been also identified as a causative agent for pleural effusion in AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/39\" class=\"abstract_t\">39</a>]. (See <a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">&quot;Cryptococcus neoformans infection outside the central nervous system&quot;</a>.)</p><p>In cryptococcal effusions, the pleural fluid is typically a serous exudate with a low nucleated cell count. Pleural fluid culture is diagnostic in 42 percent of cases [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/40\" class=\"abstract_t\">40</a>]. Cryptococcal antigen determination in pleural fluid of non-AIDS patients has proved to be a rapid and specific test [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/41\" class=\"abstract_t\">41</a>]. Therefore, serum and pleural fluid cryptococcal antigen tests should be performed in all AIDS patients with pleural effusion, since a positive result may allow early treatment and prevent dissemination. Pleural fluid culture is usually positive within a week; however, an incubation time up to two weeks may be necessary before a fluid sample is considered negative for Cryptococcus [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/37\" class=\"abstract_t\">37</a>]. Pleural biopsy has been helpful in making a definite diagnosis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/37\" class=\"abstract_t\">37</a>]. Pleural fluid adenosine deaminase concentration has been reported to be falsely elevated in cryptococcal pleural effusion [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/42\" class=\"abstract_t\">42</a>]. The pleural effusion resolves with amphotericin B, but may also resolve spontaneously [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/43\" class=\"abstract_t\">43</a>].</p><p>Other rare causes for pleural effusion in AIDS worldwide include paracoccidioidomycosis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/44\" class=\"abstract_t\">44</a>] and filariasis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/45\" class=\"abstract_t\">45</a>]. (See <a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis&quot;</a> and <a href=\"topic.htm?path=lymphatic-filariasis-treatment-and-prevention\" class=\"medical medical_review\">&quot;Lymphatic filariasis: Treatment and prevention&quot;</a> and <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Histoplasma capsulatum</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Disseminated histoplasmosis is an important opportunistic infection in AIDS; however, Histoplasma capsulatum is rarely a cause of pleural effusion in patients with or without AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/40,46\" class=\"abstract_t\">40,46</a>]. Histoplasma pleural effusion may present in association with dissemination, contiguous spread, hypersensitivity pleuritis, or active pericarditis. (See <a href=\"topic.htm?path=diagnosis-and-treatment-of-disseminated-histoplasmosis-in-hiv-uninfected-patients\" class=\"medical medical_review\">&quot;Diagnosis and treatment of disseminated histoplasmosis in HIV-uninfected patients&quot;</a>.)</p><p>The effusion is serous or serosanguineous, with a low number of nucleated cells. A cytocentrifuged pleural fluid specimen stained with Wright-Giemsa stain will demonstrate intracellular yeast typical of Histoplasma capsulatum. The pleural effusion usually resolves without treatment; however, resolution may be slow, over several months [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/40\" class=\"abstract_t\">40</a>].</p><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Toxoplasma gondii</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Toxoplasma gondii is a rare cause of pleural effusion [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/47\" class=\"abstract_t\">47</a>]. Pleural effusion may be unilateral or bilateral. A cytocentrifuged Wright-Giemsa-stained specimen of pleural fluid will demonstrate T. gondii tachyzoites within neutrophils. Tachyzoites can also be found in bronchoalveolar lavage fluid when there is concomitant pulmonary parenchymal disease.</p><p>The treatment of pulmonary T. gondii infection in HIV-infection is discussed separately. (See <a href=\"topic.htm?path=toxoplasmosis-in-hiv-infected-patients\" class=\"medical medical_review\">&quot;Toxoplasmosis in HIV-infected patients&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Leishmaniasis</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Visceral leishmaniasis is a common infection in patients with AIDS who live in endemic areas. Rare cases of pleural effusion have been reported [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/48\" class=\"abstract_t\">48</a>]. (See <a href=\"topic.htm?path=visceral-leishmaniasis-epidemiology-and-control\" class=\"medical medical_review\">&quot;Visceral leishmaniasis: Epidemiology and control&quot;</a> and <a href=\"topic.htm?path=visceral-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">&quot;Visceral leishmaniasis: Clinical manifestations and diagnosis&quot;</a> and <a href=\"topic.htm?path=visceral-leishmaniasis-treatment\" class=\"medical medical_review\">&quot;Visceral leishmaniasis: Treatment&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">MALIGNANT EFFUSIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>HIV-infected patients have an increased propensity to develop malignancies that cause pleural effusions, particularly if their CD4 count is below <span class=\"nowrap\">200/mm<sup>3</sup></span> (<a href=\"image.htm?imageKey=PULM%2F58777%7EPULM%2F71626\" class=\"graphic graphic_table graphicRef58777 graphicRef71626 \">table 1A-B</a>). Some of these (eg, Kaposi sarcoma [KS], multicentric Castleman's disease [MCD], primary effusion lymphoma [PEL]) are related to infections with human herpesvirus 8 (HHV-8) <span class=\"nowrap\">and/or</span> Epstein Barr virus (EBV) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/49\" class=\"abstract_t\">49</a>]. Although antiretroviral therapy (ART) seems to have reduced the incidence of KS, the incidence of MCD and PEL remains unchanged [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/50\" class=\"abstract_t\">50</a>]. Patients with acquired immunodeficiency syndrome (AIDS) can also develop other cancers that may cause pleural effusions; these are reviewed separately [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/3\" class=\"abstract_t\">3</a>]. (See <a href=\"topic.htm?path=hiv-infection-and-malignancy-epidemiology-and-pathogenesis\" class=\"medical medical_review\">&quot;HIV infection and malignancy: Epidemiology and pathogenesis&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Kaposi sarcoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural effusion arises in 36 to 60 percent of patients with KS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51,52\" class=\"abstract_t\">51,52</a>]. The onset of pleural effusion is preceded by the appearance of cutaneous KS lesions by several months (<a href=\"image.htm?imageKey=ONC%2F75375%7EONC%2F79013%7EONC%2F69203\" class=\"graphic graphic_picture graphicRef75375 graphicRef79013 graphicRef69203 \">picture 1A-C</a>), and usually by a fall in CD4 count to below 150 cells per microL and an increase in viral load to above 10,000 copies per mL [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/53\" class=\"abstract_t\">53</a>]. Whereas about 45 percent of subjects with skin lesions tend to have pleuro-pulmonary lesions, the majority of patients with pulmonary KS will have demonstrable skin lesions [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/50\" class=\"abstract_t\">50</a>]. Pleuritic chest pain is absent, perhaps because the visceral pleura is preferentially involved, not the parietal pleura. (See <a href=\"topic.htm?path=aids-related-kaposi-sarcoma-staging-and-treatment\" class=\"medical medical_review\">&quot;AIDS-related Kaposi sarcoma: Staging and treatment&quot;</a> and <a href=\"topic.htm?path=pulmonary-involvement-in-aids-related-kaposi-sarcoma\" class=\"medical medical_review\">&quot;Pulmonary involvement in AIDS-related Kaposi sarcoma&quot;</a>.)</p><p>In addition to the pleural effusion, the chest radiograph typically shows unilateral or bilateral interstitial <span class=\"nowrap\">and/or</span> alveolar infiltrates; hilar or mediastinal adenopathy is present in 25 to 60 percent of patients with pleuropulmonary Kaposi sarcoma [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51,52\" class=\"abstract_t\">51,52</a>]. Pleural effusions are predominantly bilateral and are large to massive in size (<a href=\"image.htm?imageKey=PULM%2F87395\" class=\"graphic graphic_diagnosticimage graphicRef87395 \">image 1</a>). Pleural fluid was serosanguineous and free flowing in a majority of patients; hemorrhagic effusions are also seen.</p><p>In a review of 105 postmortem examinations of patients with KS, thoracic findings included bilateral hemorrhagic pleural effusions, purplish lesions of KS on the visceral pleura, and infiltration of lung parenchymal lymphatics and mediastinal lymph nodes [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51\" class=\"abstract_t\">51</a>]. Effusions are typically serosanguineous due to hemorrhage from highly vascular lesions of the visceral pleura. Occasionally, a characteristic parietal pleural lesion can be observed during thoracoscopy (<a href=\"image.htm?imageKey=PULM%2F91086\" class=\"graphic graphic_picture graphicRef91086 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/54\" class=\"abstract_t\">54</a>].</p><p>Pleural fluid characteristics are as follows:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The nucleated cell counts are generally low, and there is mononuclear cell predominance</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The fluid is exudative</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The LDH varies between 111 and 330 <span class=\"nowrap\">IU/L</span></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The pleural fluid glucose concentration is greater than 60 <span class=\"nowrap\">mg/dL</span> (3.3 <span class=\"nowrap\">mmol/L)</span></p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cytologic examination of the pleural fluid is unrewarding</p><p/><p>Chylous effusions have been increasingly recognized in KS, but the hemorrhagic nature of the effusion may mask the typical appearance of a chylothorax [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51,55\" class=\"abstract_t\">51,55</a>]. A pleural fluid triglyceride concentration more than 110 <span class=\"nowrap\">mg/dL</span> will suggest the presence of a chylous effusion; the presence of chylomicrons will confirm the diagnosis. (See <a href=\"topic.htm?path=etiology-clinical-presentation-and-diagnosis-of-chylothorax\" class=\"medical medical_review\">&quot;Etiology, clinical presentation, and diagnosis of chylothorax&quot;</a>.)</p><p>The diagnosis of pleural KS cannot be made by percutaneous pleural biopsy, because the lesions are rarely found on the parietal pleura. Although open lung biopsy establishes the diagnosis in 75 percent of cases, the high <span class=\"nowrap\">risk/benefit</span> ratio makes this procedure of limited value [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/56\" class=\"abstract_t\">56</a>]. The finding of characteristic red endobronchial lesions on bronchoscopy essentially establishes the diagnosis of pleural Kaposi sarcoma in the proper clinical setting, such as a patient with bilateral hemorrhagic effusions [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/56\" class=\"abstract_t\">56</a>]. Occasionally, thoracoscopy can demonstrate a typical KS lesion (<a href=\"image.htm?imageKey=PULM%2F91086\" class=\"graphic graphic_picture graphicRef91086 \">picture 2</a>) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/54\" class=\"abstract_t\">54</a>]. While human herpes virus (HHV)-8 viral load in bronchoalveolar lavage (BAL) fluid was shown to be elevated in tracheobronchial KS, it has not been tested in pleural KS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/57\" class=\"abstract_t\">57</a>].</p><p>Reports of therapy directed to the pleural space are few. Effusions from KS often need drainage for symptomatic relief. <a href=\"topic.htm?path=tetracycline-drug-information\" class=\"drug drug_general\">Tetracycline</a> pleurodesis was ineffective in a limited number of patients [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51\" class=\"abstract_t\">51</a>]. Radiation therapy has been used as a palliative measure [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/58\" class=\"abstract_t\">58</a>]. A single case report indicated resolution of pleural and pericardial effusion following therapy with intravenous liposomal <a href=\"topic.htm?path=doxorubicin-conventional-drug-information\" class=\"drug drug_general\">doxorubicin</a>, pleural drainage, and one session of whole lung irradiation [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/59\" class=\"abstract_t\">59</a>]. Other potential newer therapies that are being tried include: interferon-alpha, mTOR inhibitors such as rapamycin, or angiogenesis inhibitors such as <a href=\"topic.htm?path=lenalidomide-drug-information\" class=\"drug drug_general\">lenalidomide</a>, <a href=\"topic.htm?path=bevacizumab-including-biosimilars-of-bevacizumab-drug-information\" class=\"drug drug_general\">bevacizumab</a>, <a href=\"topic.htm?path=sunitinib-drug-information\" class=\"drug drug_general\">sunitinib</a>, or <a href=\"topic.htm?path=sorafenib-drug-information\" class=\"drug drug_general\">sorafenib</a> [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/60,61\" class=\"abstract_t\">60,61</a>]. Anecdotally, some patients may respond to treatment of KS with antiretroviral therapy. The management of malignant pleural effusions and treatment of KS are reviewed separately. (See <a href=\"topic.htm?path=aids-related-kaposi-sarcoma-staging-and-treatment\" class=\"medical medical_review\">&quot;AIDS-related Kaposi sarcoma: Staging and treatment&quot;</a> and <a href=\"topic.htm?path=management-of-malignant-pleural-effusions\" class=\"medical medical_review\">&quot;Management of malignant pleural effusions&quot;</a>.)</p><p>About two-thirds of patients with KS associated with the immune reconstitution inflammatory syndrome (IRIS) will have pleural effusions, following initiation of ART [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/62\" class=\"abstract_t\">62</a>]. The management of IRIS is described separately. (See <a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome\" class=\"medical medical_review\">&quot;Immune reconstitution inflammatory syndrome&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Multicentric Castleman's disease</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Multicentric Castleman's disease (MCD) is a lymphoproliferative disorder that is highly associated with HIV and HHV-8 infection. Typical pulmonary findings are reticular or nodular pulmonary parenchymal opacities, mediastinal adenopathy and, less commonly, bilateral pleural effusions [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/63\" class=\"abstract_t\">63</a>]. The diagnosis is usually made on a lymph node biopsy. (See <a href=\"topic.htm?path=multicentric-castlemans-disease\" class=\"medical medical_review\">&quot;Multicentric Castleman's disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Lymphoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>B-cell, non-Hodgkin lymphoma (NHL) arises in 5 to 10 percent of patients with AIDS. The reported prevalence of pleural effusion due to lymphoma varies from 1 to 16 percent [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/3,16,64\" class=\"abstract_t\">3,16,64</a>]. However, an autopsy series documented pleural effusion in 65 percent of those with thoracic involvement with lymphoma and in about 25 percent of all patients with NHL [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65\" class=\"abstract_t\">65</a>]. (See <a href=\"topic.htm?path=aids-related-lymphomas-clinical-manifestations-diagnosis-and-staging-of-systemic-lymphoma\" class=\"medical medical_review\">&quot;AIDS-related lymphomas: Clinical manifestations, diagnosis, and staging of systemic lymphoma&quot;</a>.)</p><p>Pulmonary involvement with non-Hodgkin lymphoma is more commonly seen in patients with advanced HIV infection [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65\" class=\"abstract_t\">65</a>]. Peripheral lymphadenopathy, hepatosplenomegaly, and elevated serum lactic dehydrogenase (LDH) were common. Pleural effusions were associated with pulmonary nodules, areas of consolidation, or masses; about 60 percent had associated thoracic lymphadenopathy. Pleural effusions caused by NHL may have a mass effect, whereas effusions from primary effusion lymphoma do not. (See <a href=\"#H15\" class=\"local\">'Primary effusion lymphoma'</a> below.)</p><p>When NHL involves the pleura, effusions tend to be large, serosanguineous, lymphocyte-predominant exudates with a normal glucose, and a high LDH concentration [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65\" class=\"abstract_t\">65</a>]. Pleural fluid cytology has been reported to be diagnostic in about 60 to 75 percent of cases [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65,66\" class=\"abstract_t\">65,66</a>]. Pleural biopsy also had a high diagnostic yield [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65\" class=\"abstract_t\">65</a>]; flow cytometric examination of pleural fluid has also been useful in establishing the diagnosis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/67\" class=\"abstract_t\">67</a>].</p><p>The treatment of NHL in HIV infected patients is reviewed separately. (See <a href=\"topic.htm?path=aids-related-lymphomas-treatment-of-systemic-lymphoma\" class=\"medical medical_review\">&quot;AIDS-related lymphomas: Treatment of systemic lymphoma&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Primary effusion lymphoma</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Primary effusion lymphoma (PEL) is a high-grade NHL of B-cell origin that is predominantly found in HIV-seropositive homosexual men between the ages of 30 and 50 years [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/68-72\" class=\"abstract_t\">68-72</a>]. PEL is strongly associated with HHV-8 infection. Preexisting KS has been reported in 33 to 70 percent of patients with PEL [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/73\" class=\"abstract_t\">73</a>]. Increasingly co-infection with EBV has been reported in PEL [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/74\" class=\"abstract_t\">74</a>]. (See <a href=\"topic.htm?path=aids-related-lymphomas-primary-effusion-lymphoma\" class=\"medical medical_review\">&quot;AIDS-related lymphomas: Primary effusion lymphoma&quot;</a>.)</p><p>PEL cell lines have been shown to generate excessive vascular endothelial growth factor <span class=\"nowrap\">(VEGF)/vascular</span> permeability factor (VPF); <span class=\"nowrap\">VEGF/VPF</span> may contribute to excessive fluid formation in the pleural space, pericardial sac, and abdomen [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/75\" class=\"abstract_t\">75</a>]. The absence of lymphadenopathy suggests that central lymphatic obstruction by lymphoma is not the mechanism for fluid formation.</p><p>Chest computed tomography (CT) shows pleural effusion with adjacent parietal pleural thickening in the absence of lung parenchymal lesions or mediastinal lymphadenopathy. Pericardial effusion and ascites are other common radiological findings. Peripheral lymphadenopathy and bone marrow involvement are unusual findings [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/76\" class=\"abstract_t\">76</a>].</p><p>The diagnosis of PEL is usually made by the cytologic examination of pleural fluid (<a href=\"image.htm?imageKey=PULM%2F58183\" class=\"graphic graphic_picture graphicRef58183 \">picture 3</a>). Pleural fluid immunocytochemistry shows malignant cells that are often positive for CD45 and CD30, and variable for epithelial membrane antigen [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/77,78\" class=\"abstract_t\">77,78</a>]. The nuclei usually stain positive for HHV-8; the most common method for detecting HHV-8 positivity is immunohistochemical staining for the latent viral gene product known as latency-associated nuclear antigen (LANA-1) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/79\" class=\"abstract_t\">79</a>].</p><p>The treatment of PEL is discussed separately (see <a href=\"topic.htm?path=aids-related-lymphomas-primary-effusion-lymphoma\" class=\"medical medical_review\">&quot;AIDS-related lymphomas: Primary effusion lymphoma&quot;</a>). Median survival with treatment in PEL was 6.2 months. The predictors of poor outcome were poor performance status and having not received ART prior to diagnosis [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/80\" class=\"abstract_t\">80</a>].</p><p class=\"headingAnchor\" id=\"H16\"><span class=\"h2\">Lung cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The incidence of lung cancer is significantly increased in patients with HIV infection, and malignant pleural effusions are a relatively common sequela of lung cancer in patients with <span class=\"nowrap\">HIV/AIDS</span>. (See <a href=\"topic.htm?path=hiv-infection-and-malignancy-management-considerations#H876177289\" class=\"medical medical_review\">&quot;HIV infection and malignancy: Management considerations&quot;, section on 'Lung cancer'</a>.)</p><p class=\"headingAnchor\" id=\"H17\"><span class=\"h1\">OTHER NONINFECTIOUS CAUSES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Other noninfectious disorders that may cause pleural effusions in HIV-infected patients include hypoalbuminemia, heart failure, uremia, and pulmonary embolism (<a href=\"image.htm?imageKey=PULM%2F58777%7EPULM%2F71626\" class=\"graphic graphic_table graphicRef58777 graphicRef71626 \">table 1A-B</a>)&nbsp;[<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1\" class=\"abstract_t\">1</a>].</p><p class=\"headingAnchor\" id=\"H18\"><span class=\"h2\">Hypoalbuminemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypoalbuminemia has been encountered as a cause for pleural effusion in 7 to 15 percent of hospitalized patients with acquired immunodeficiency syndrome (AIDS) [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1,2\" class=\"abstract_t\">1,2</a>]. Because hypoalbuminemia is a recognized problem in progressive AIDS, hypoalbuminemic pleural effusions may become more prevalent as the infectious complications of AIDS are managed more effectively. Hypoalbuminemic effusions are small to moderate in size, bilateral, and transudative. The nucleated cell count is low and mononuclear cells predominate.</p><p class=\"headingAnchor\" id=\"H19\"><span class=\"h2\">Heart failure</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Pleural effusion secondary to cardiac failure has been noted in hospitalized patients with AIDS [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2\" class=\"abstract_t\">2</a>]. In this setting, dilated cardiomyopathy is usually caused by infectious myocarditis; toxoplasmosis, cytomegalovirus, and HIV have all been implicated [<a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/81\" class=\"abstract_t\">81</a>]. Pleural effusions are small, unilateral or bilateral, and transudative. The effusions generally are clinically unimportant and resolve with treatment of the heart failure. (See <a href=\"topic.htm?path=cardiac-and-vascular-disease-in-hiv-infected-patients#H7\" class=\"medical medical_review\">&quot;Cardiac and vascular disease in HIV-infected patients&quot;, section on 'Myocardial disease'</a>.)</p><p class=\"headingAnchor\" id=\"H20\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The diagnostic evaluation of pleural effusions in HIV-infected patients follows a similar algorithm to that for HIV-noninfected patients; however certain additional tests may be important (<a href=\"image.htm?imageKey=PULM%2F58777%7EPULM%2F71626\" class=\"graphic graphic_table graphicRef58777 graphicRef71626 \">table 1A-B</a>) (see <a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">&quot;Diagnostic evaluation of a pleural effusion in adults: Initial testing&quot;</a>). If these tests are not diagnostic, further investigation should follow the steps for an undiagnosed pleural effusion. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">&quot;Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H21\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The majority of pleural effusions in patients with acquired immunodeficiency syndrome (AIDS) are secondary to infection; however, about a third are due to noninfectious causes. (See <a href=\"#H1\" class=\"local\">'Introduction'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Bacterial pneumonia is the single most common cause of pleural effusion in AIDS, accounting for approximately 30 percent of effusions in hospitalized AIDS patients. (See <a href=\"#H3\" class=\"local\">'Bacterial pneumonia'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural effusion is an unusual manifestation of Pneumocystis jirovecii (PCP) infection in HIV-infected patients. PCP pleural effusions are usually small to moderate in size, either unilateral or bilateral, and serous to bloody in appearance. Trophozoite or cyst forms of P. jirovecii are found on Diff-Quik or silver stains of pleural fluid, respectively. (See <a href=\"#H4\" class=\"local\">'Pneumocystis jirovecii'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mycobacterial infection accounts for 8 to 10 percent of pleural effusions in patients with AIDS; depending on the patient population, M. tuberculosis or M. avium complex may be more common. Acid-fast stain is positive in 15 percent of pleural fluid samples and 69 percent of pleural biopsy specimens; granulomas are present in up to 88 percent of the biopsies. Molecular testing for Mycobacterium <span class=\"nowrap\">tuberculosis/resistance</span> to rifampicin <span class=\"nowrap\">(MTB/RIF)</span> assay has some value for rapid diagnosis of pleural tuberculosis on pleural tissue but not in pleural fluid where its diagnostic sensitivity is low.(See <a href=\"#H5\" class=\"local\">'Mycobacteria'</a> above.) &#160;</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other opportunistic infections may occasionally cause pleural effusions in HIV-infected patients, including Cryptococcus, Histoplasmosis, and Toxoplasma. (See <a href=\"#H2\" class=\"local\">'Infectious causes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pleural effusions are common among patients with Kaposi sarcoma (KS); the fluid is usually serosanguineous to hemorrhagic. Virtually all patients have skin lesions of KS and many have endobronchial KS. Pleural cytology and pleural biopsy are negative. Pleuroscopy can detect typical pleural KS lesions. (See <a href=\"#H12\" class=\"local\">'Kaposi sarcoma'</a> above.) </p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>When non-Hodgkin lymphoma (NHL) involves the pleura, concomitant pulmonary nodules, masses, or consolidation are also present on computed tomography; about 60 percent of patients have mediastinal lymphadenopathy. Pleural fluid cytology and flow cytometry, pleural biopsy, and transbronchial biopsy of lung lesions have high diagnostic yields. (See <a href=\"#H14\" class=\"local\">'Lymphoma'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Primary effusion lymphoma (PEL) is a high-grade NHL of B-cell origin. Unlike pleural effusions from MCD and other lymphomas, there is no associated lymphadenopathy. The diagnosis of PEL is usually made by the cytologic examination of pleural fluid with immunohistochemical staining for HHV-8, such as the viral gene product, latency-associated nuclear antigen (LANA-1). (See <a href=\"#H15\" class=\"local\">'Primary effusion lymphoma'</a> above.) The median survival with treatment has been reported to vary from three to nine months.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Other noninfectious disorders that may cause pleural effusions in HIV-infected patients include hypoalbuminemia, heart failure, and pulmonary embolism. (See <a href=\"#H17\" class=\"local\">'Other noninfectious causes'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnostic evaluation of pleural effusions in HIV-infected patients follows a similar algorithm to that for HIV-noninfected patients; however certain additional tests may be important. (See <a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">&quot;Diagnostic evaluation of a pleural effusion in adults: Initial testing&quot;</a>.)</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/1\" class=\"nounderline abstract_t\">Afessa B. Pleural effusion and pneumothorax in hospitalized patients with HIV infection: the Pulmonary Complications, ICU support, and Prognostic Factors of Hospitalized Patients with HIV (PIP) Study. Chest 2000; 117:1031.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/2\" class=\"nounderline abstract_t\">Joseph J, Strange C, Sahn SA. Pleural effusions in hospitalized patients with AIDS. Ann Intern Med 1993; 118:856.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/3\" class=\"nounderline abstract_t\">Armbruster C, Schalleschak J, Vetter N, Pokieser L. Pleural effusions in human immunodeficiency virus-infected patients. Correlation with concomitant pulmonary diseases. Acta Cytol 1995; 39:698.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/4\" class=\"nounderline abstract_t\">Gil Suay V, Cordero PJ, Mart&iacute;nez E, et al. Parapneumonic effusions secondary to community-acquired bacterial pneumonia in human immunodeficiency virus-infected patients. Eur Respir J 1995; 8:1934.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/5\" class=\"nounderline abstract_t\">Grau I, Pallares R, Tubau F, et al. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch Intern Med 2005; 165:1533.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/6\" class=\"nounderline abstract_t\">Schlossbauer T, Schmidt GP, Bogner JR, et al. Pulmonary radiological characteristics in patients with HIV infection at the time of highly active antiretroviral therapy (HAART). Eur J Med Res 2007; 12:341.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/7\" class=\"nounderline abstract_t\">Coker RJ. Empyema thoracis in AIDS. J R Soc Med 1994; 87:65.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/8\" class=\"nounderline abstract_t\">Viejo G, de la Iglesia P, Otero L, et al. Bordetella bronchiseptica pleural infection in a patient with AIDS. Scand J Infect Dis 2002; 34:628.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/9\" class=\"nounderline abstract_t\">Horowitz ML, Schiff M, Samuels J, et al. Pneumocystis carinii pleural effusion. Pathogenesis and pleural fluid analysis. Am Rev Respir Dis 1993; 148:232.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/10\" class=\"nounderline abstract_t\">Balachandran I, Jones DB, Humphrey DM. A case of Pneumocystis carinii in pleural fluid with cytologic, histologic and ultrastructural documentation. Acta Cytol 1990; 34:486.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/11\" class=\"nounderline abstract_t\">Elwood LJ, Dobrzanski D, Feuerstein IM, Solomon D. Pneumocystis carinii in pleural fluid. The cytologic appearance. Acta Cytol 1991; 35:761.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/12\" class=\"nounderline abstract_t\">Jayes RL, Kamerow HN, Hasselquist SM, et al. Disseminated pneumocystosis presenting as a pleural effusion. Chest 1993; 103:306.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/13\" class=\"nounderline abstract_t\">Abati AD, Opitz L, Brones C, et al. Cytology of extrapulmonary Pneumocystis carinii infection in the acquired immunodeficiency syndrome. Acta Cytol 1992; 36:440.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/14\" class=\"nounderline abstract_t\">Beers MF, Sohn M, Swartz M. Recurrent pneumothorax in AIDS patients with Pneumocystis pneumonia. A clinicopathologic report of three cases and review of the literature. Chest 1990; 98:266.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/15\" class=\"nounderline abstract_t\">Dyner TS, Lang W, Busch DF, Gordon PR. Intravascular and pleural involvement by Pneumocystis carinii in a patient with the acquired immunodeficiency syndrome (AIDS). Ann Intern Med 1989; 111:94.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/16\" class=\"nounderline abstract_t\">Soubani AO, Michelson MK, Karnik A. Pleural fluid findings in patients with the acquired immunodeficiency syndrome: correlation with concomitant pulmonary disease. South Med J 1999; 92:400.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/17\" class=\"nounderline abstract_t\">Koh WJ, Yu CM, Suh GY, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis 2006; 10:1001.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/18\" class=\"nounderline abstract_t\">Relkin F, Aranda CP, Garay SM, et al. Pleural tuberculosis and HIV infection. Chest 1994; 105:1338.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/19\" class=\"nounderline abstract_t\">Kapetanopoulos A, Habboub A, Gillam LD, Ross JW. Cardiac tamponade as a result of Mycobacterium avium-complex pleural effusion. Conn Med 2004; 68:147.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/20\" class=\"nounderline abstract_t\">Gopi A, Madhavan SM, Sharma SK, Sahn SA. Diagnosis and treatment of tuberculous pleural effusion in 2006. Chest 2007; 131:880.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/21\" class=\"nounderline abstract_t\">Lawn SD, Pisell TL, Hirsch CS, et al. Anatomically compartmentalized human immunodeficiency virus replication in HLA-DR+ cells and CD14+ macrophages at the site of pleural tuberculosis coinfection. J Infect Dis 2001; 184:1127.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/22\" class=\"nounderline abstract_t\">Lawn SD, Mwaba P, Bates M, et al. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013; 13:349.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/23\" class=\"nounderline abstract_t\">Friedrich SO, von Groote-Bidlingmaier F, Diacon AH. Xpert MTB/RIF assay for diagnosis of pleural tuberculosis. J Clin Microbiol 2011; 49:4341.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/24\" class=\"nounderline abstract_t\">Rufai SB, Singh A, Kumar P, et al. Performance of Xpert MTB/RIF Assay in Diagnosis of Pleural Tuberculosis by Use of Pleural Fluid Samples. J Clin Microbiol 2015; 53:3636.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/25\" class=\"nounderline abstract_t\">Maynard-Smith L, Larke N, Peters JA, Lawn SD. Diagnostic accuracy of the Xpert MTB/RIF assay for extrapulmonary and pulmonary tuberculosis when testing non-respiratory samples: a systematic review. BMC Infect Dis 2014; 14:709.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/26\" class=\"nounderline abstract_t\">Kitinya JN, Richter C, Perenboom R, et al. Influence of HIV status on pathological changes in tuberculous pleuritis. Tuber Lung Dis 1994; 75:195.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/27\" class=\"nounderline abstract_t\">Riantawan P, Chaowalit P, Wongsangiem M, Rojanaraweewong P. Diagnostic value of pleural fluid adenosine deaminase in tuberculous pleuritis with reference to HIV coinfection and a Bayesian analysis. Chest 1999; 116:97.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/28\" class=\"nounderline abstract_t\">Conde MB, Loivos AC, Rezende VM, et al. Yield of sputum induction in the diagnosis of pleural tuberculosis. Am J Respir Crit Care Med 2003; 167:723.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/29\" class=\"nounderline abstract_t\">Breton G, Duval X, Estellat C, et al. Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy. Clin Infect Dis 2004; 39:1709.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/30\" class=\"nounderline abstract_t\">Lawn SD, Myer L, Bekker LG, Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 2007; 21:335.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/31\" class=\"nounderline abstract_t\">Buckingham SJ, Haddow LJ, Shaw PJ, Miller RF. Immune reconstitution inflammatory syndrome in HIV-infected patients with mycobacterial infections starting highly active anti-retroviral therapy. Clin Radiol 2004; 59:505.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/32\" class=\"nounderline abstract_t\">Uttamchandani RB, Daikos GL, Reyes RR, et al. Nocardiosis in 30 patients with advanced human immunodeficiency virus infection: clinical features and outcome. Clin Infect Dis 1994; 18:348.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/33\" class=\"nounderline abstract_t\">Inthraburan K, Wongsa A. Empyema thoracis due to nocardiosis and Mycobacterium tuberculosis mixed infections in an AIDS patient. Southeast Asian J Trop Med Public Health 2009; 40:776.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/34\" class=\"nounderline abstract_t\">Cartwright E, Rouphael N, Jain S, Ilksoy N. Pleural effusion in a patient with AIDS. Clin Infect Dis 2008; 46:1887.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/35\" class=\"nounderline abstract_t\">Cadranel JL, Chouaid C, Denis M, et al. Causes of pleural effusion in 75 HIV-infected patients. Chest 1993; 104:655.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/36\" class=\"nounderline abstract_t\">Miller RF, Howling SJ, Reid AJ, Shaw PJ. Pleural effusions in patients with AIDS. Sex Transm Infect 2000; 76:122.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/37\" class=\"nounderline abstract_t\">Katz AS, Niesenbaum L, Mass B. Pleural effusion as the initial manifestation of disseminated cryptococcosis in acquired immune deficiency syndrome. Diagnosis by pleural biopsy. Chest 1989; 96:440.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/38\" class=\"nounderline abstract_t\">Grum EE, Schwab R, Margolis ML. Cryptococcal pleural effusion preceding cryptococcal meningitis in AIDS. Am J Med Sci 1991; 301:329.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/39\" class=\"nounderline abstract_t\">Shankar EM, Kumarasamy N, Bella D, et al. Pneumonia and pleural effusion due to Cryptococcus laurentii in a clinically proven case of AIDS. Can Respir J 2006; 13:275.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/40\" class=\"nounderline abstract_t\">Marshall BC, Cox JK Jr, Carroll KC, Morrison RE. Histoplasmosis as a cause of pleural effusion in the acquired immunodeficiency syndrome. Am J Med Sci 1990; 300:98.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/41\" class=\"nounderline abstract_t\">Young EJ, Hirsh DD, Fainstein V, Williams TW. Pleural effusions due to Cryptococcus neoformans: a review of the literature and report of two cases with cryptococcal antigen determinations. Am Rev Respir Dis 1980; 121:743.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/42\" class=\"nounderline abstract_t\">Yoshino Y, Kitazawa T, Tatsuno K, et al. Cryptococcal pleuritis containing a high level of adenosine deaminase in a patient with AIDS: a case report. Respiration 2010; 79:153.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/43\" class=\"nounderline abstract_t\">Newman TG, Soni A, Acaron S, Huang CT. Pleural cryptococcosis in the acquired immune deficiency syndrome. Chest 1987; 91:459.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/44\" class=\"nounderline abstract_t\">Paniago AM, de Freitas AC, Aguiar ES, et al. Paracoccidioidomycosis in patients with human immunodeficiency virus: review of 12 cases observed in an endemic region in Brazil. J Infect 2005; 51:248.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/45\" class=\"nounderline abstract_t\">Roy I, Mukhopadhyay C, Ayyagari A. Multisystem involvement of microfilaria in a HIV positive patient. Nepal Med Coll J 2004; 6:64.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/46\" class=\"nounderline abstract_t\">Wheat J, French ML, Kohler RB, et al. The diagnostic laboratory tests for histoplasmosis: analysis of experience in a large urban outbreak. Ann Intern Med 1982; 97:680.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/47\" class=\"nounderline abstract_t\">Schnapp LM, Geaghan SM, Campagna A, et al. Toxoplasma gondii pneumonitis in patients infected with the human immunodeficiency virus. Arch Intern Med 1992; 152:1073.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/48\" class=\"nounderline abstract_t\">Chenoweth CE, Singal S, Pearson RD, et al. Acquired immunodeficiency syndrome-related visceral leishmaniasis presenting in a pleural effusion. Chest 1993; 103:648.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/49\" class=\"nounderline abstract_t\">Chang Y, Cesarman E, Pessin MS, et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266:1865.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/50\" class=\"nounderline abstract_t\">Borie R, Cadranel J, Guihot A, et al. Pulmonary manifestations of human herpesvirus-8 during HIV infection. Eur Respir J 2013; 42:1105.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/51\" class=\"nounderline abstract_t\">O'Brien RF, Cohn DL. Serosanguineous pleural effusions in AIDS-associated Kaposi's sarcoma. Chest 1989; 96:460.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/52\" class=\"nounderline abstract_t\">Sivit CJ, Schwartz AM, Rockoff SD. Kaposi's sarcoma of the lung in AIDS: radiologic-pathologic analysis. AJR Am J Roentgenol 1987; 148:25.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/53\" class=\"nounderline abstract_t\">Maurer T, Ponte M, Leslie K. HIV-associated Kaposi's sarcoma with a high CD4 count and a low viral load. N Engl J Med 2007; 357:1352.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/54\" class=\"nounderline abstract_t\">Sridar S, Garza EG, Cox J, Rumbak MJ. Serosanguineous Pleural Effusions in a Patient With HIV and Kaposi Sarcoma: Pleuroscopic Findings. J Bronchology Interv Pulmonol 2011; 18:337.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/55\" class=\"nounderline abstract_t\">Judson MA, Postic B. Chylothorax in a patient with AIDS and Kaposi's sarcoma. South Med J 1990; 83:322.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/56\" class=\"nounderline abstract_t\">Fan W, Bubman D, Chadburn A, et al. Distinct subsets of primary effusion lymphoma can be identified based on their cellular gene expression profile and viral association. J Virol 2005; 79:1244.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/57\" class=\"nounderline abstract_t\">Tamm M, Reichenberger F, McGandy CE, et al. Diagnosis of pulmonary Kaposi's sarcoma by detection of human herpes virus 8 in bronchoalveolar lavage. Am J Respir Crit Care Med 1998; 157:458.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/58\" class=\"nounderline abstract_t\">Nobler MP. Pulmonary irradiation for Kaposi's sarcoma in AIDS. Am J Clin Oncol 1985; 8:441.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/59\" class=\"nounderline abstract_t\">Maradona JA, Carton JA, Asensi V, Rodr&iacute;guez-Guardado A. AIDS-related Kaposi's sarcoma with chylothorax and pericardial involvement satisfactorily treated with liposomal doxorubicin. AIDS 2002; 16:806.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/60\" class=\"nounderline abstract_t\">Sullivan RJ, Pantanowitz L. New drug targets in Kaposi sarcoma. Expert Opin Ther Targets 2010; 14:1355.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/61\" class=\"nounderline abstract_t\">Di Lorenzo G, Konstantinopoulos PA, Pantanowitz L, et al. Management of AIDS-related Kaposi's sarcoma. Lancet Oncol 2007; 8:167.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/62\" class=\"nounderline abstract_t\">Godoy MC, Rouse H, Brown JA, et al. Imaging features of pulmonary Kaposi sarcoma-associated immune reconstitution syndrome. AJR Am J Roentgenol 2007; 189:956.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/63\" class=\"nounderline abstract_t\">Guihot A, Couderc LJ, Agbalika F, et al. Pulmonary manifestations of multicentric Castleman's disease in HIV infection: a clinical, biological and radiological study. Eur Respir J 2005; 26:118.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/64\" class=\"nounderline abstract_t\">Batungwanayo J, Taelman H, Allen S, et al. Pleural effusion, tuberculosis and HIV-1 infection in Kigali, Rwanda. AIDS 1993; 7:73.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/65\" class=\"nounderline abstract_t\">Eisner MD, Kaplan LD, Herndier B, Stulbarg MS. The pulmonary manifestations of AIDS-related non-Hodgkin's lymphoma. Chest 1996; 110:729.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/66\" class=\"nounderline abstract_t\">Sider L, Weiss AJ, Smith MD, et al. Varied appearance of AIDS-related lymphoma in the chest. Radiology 1989; 171:629.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/67\" class=\"nounderline abstract_t\">Lee AM, Katner HP. AIDS-related lymphoma diagnosed by flow cytometry of a pleural effusion. South Med J 1991; 84:1278.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/68\" class=\"nounderline abstract_t\">Cesarman E, Chang Y, Moore PS, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 1995; 332:1186.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/69\" class=\"nounderline abstract_t\">Horenstein MG, Nador RG, Chadburn A, et al. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 1997; 90:1186.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/70\" class=\"nounderline abstract_t\">Nador RG, Cesarman E, Chadburn A, et al. Primary effusion lymphoma: a distinct clinicopathologic entity associated with the Kaposi's sarcoma-associated herpes virus. Blood 1996; 88:645.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/71\" class=\"nounderline abstract_t\">Sider L, Horton ES. Pleural effusion as a presentation of AIDS-related lymphoma. Invest Radiol 1989; 24:150.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/72\" class=\"nounderline abstract_t\">Green I, Espiritu E, Ladanyi M, et al. Primary lymphomatous effusions in AIDS: a morphological, immunophenotypic, and molecular study. Mod Pathol 1995; 8:39.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/73\" class=\"nounderline abstract_t\">Ammari ZA, Mollberg NM, Abdelhady K, et al. Diagnosis and management of primary effusion lymphoma in the immunocompetent and immunocompromised hosts. Thorac Cardiovasc Surg 2013; 61:343.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/74\" class=\"nounderline abstract_t\">Lacoste V, Judde JG, Bestett G, et al. Virological and molecular characterisation of a new B lymphoid cell line, established from an AIDS patient with primary effusion lymphoma, harbouring both KSHV/HHV8 and EBV viruses. Leuk Lymphoma 2000; 38:401.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/75\" class=\"nounderline abstract_t\">Aoki Y, Tosato G. Vascular endothelial growth factor/vascular permeability factor in the pathogenesis of primary effusion lymphomas. Leuk Lymphoma 2001; 41:229.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/76\" class=\"nounderline abstract_t\">Morassut S, Vaccher E, Balestreri L, et al. HIV-associated human herpesvirus 8-positive primary lymphomatous effusions: radiologic findings in six patients. Radiology 1997; 205:459.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/77\" class=\"nounderline abstract_t\">Brimo F, Michel RP, Khetani K, Auger M. Primary effusion lymphoma: a series of 4 cases and review of the literature with emphasis on cytomorphologic and immunocytochemical differential diagnosis. Cancer 2007; 111:224.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/78\" class=\"nounderline abstract_t\">Ascoli V, Mastroianni CM, Galati V, et al. Primary effusion lymphoma containing human herpesvirus 8 DNA in two AIDS patients with Kaposi's sarcoma. Haematologica 1998; 83:8.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/79\" class=\"nounderline abstract_t\">Du MQ, Bacon CM, Isaacson PG. Kaposi sarcoma-associated herpesvirus/human herpesvirus 8 and lymphoproliferative disorders. J Clin Pathol 2007; 60:1350.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/80\" class=\"nounderline abstract_t\">Boulanger E, G&eacute;rard L, Gabarre J, et al. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 2005; 23:4372.</a></li><li><a href=\"https://www.uptodate.com/contents/pleural-effusions-in-hiv-infected-patients/abstract/81\" class=\"nounderline abstract_t\">Acierno LJ. Cardiac complications in acquired immunodeficiency syndrome (AIDS): a review. J Am Coll Cardiol 1989; 13:1144.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 6693 Version 12.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H21\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">INFECTIOUS CAUSES</a><ul><li><a href=\"#H3\" id=\"outline-link-H3\">Bacterial pneumonia</a></li><li><a href=\"#H4\" id=\"outline-link-H4\">Pneumocystis jirovecii</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Mycobacteria</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Nocardia</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Cryptococcus</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Histoplasma capsulatum</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Toxoplasma gondii</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Leishmaniasis</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">MALIGNANT EFFUSIONS</a><ul><li><a href=\"#H12\" id=\"outline-link-H12\">Kaposi sarcoma</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Multicentric Castleman's disease</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Lymphoma</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Primary effusion lymphoma</a></li><li><a href=\"#H16\" id=\"outline-link-H16\">Lung cancer</a></li></ul></li><li><a href=\"#H17\" id=\"outline-link-H17\">OTHER NONINFECTIOUS CAUSES</a><ul><li><a href=\"#H18\" id=\"outline-link-H18\">Hypoalbuminemia</a></li><li><a href=\"#H19\" id=\"outline-link-H19\">Heart failure</a></li></ul></li><li><a href=\"#H20\" id=\"outline-link-H20\">DIAGNOSIS</a></li><li><a href=\"#H21\" id=\"outline-link-H21\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PULM/6693|DiagnosticImage\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"DIAGNOSTIC IMAGES\">DIAGNOSTIC IMAGES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/87395\" class=\"graphic graphic_diagnosticimage\">- Hemorrhagic pleural effusion in Kaposi sarcoma</a></li></ul></li><li><div id=\"PULM/6693|PIC\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"PICTURES\">PICTURES</a></div><ul><li><a href=\"image.htm?imageKey=ONC/75375\" class=\"graphic graphic_picture\">- AIDS related KS skin</a></li><li><a href=\"image.htm?imageKey=ONC/79013\" class=\"graphic graphic_picture\">- KS yellow perilesional halo</a></li><li><a href=\"image.htm?imageKey=ONC/69203\" class=\"graphic graphic_picture\">- KS plaque like lesion</a></li><li><a href=\"image.htm?imageKey=PULM/91086\" class=\"graphic graphic_picture\">- Pleural KS </a></li><li><a href=\"image.htm?imageKey=PULM/58183\" class=\"graphic graphic_picture\">- PEL staining</a></li></ul></li><li><div id=\"PULM/6693|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PULM/58777\" class=\"graphic graphic_table\">- Pleural effusions in HIV I</a></li><li><a href=\"image.htm?imageKey=PULM/71626\" class=\"graphic graphic_table\">- Pleural effusions in HIV II</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-kaposi-sarcoma-staging-and-treatment\" class=\"medical medical_review\">AIDS-related Kaposi sarcoma: Staging and treatment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-lymphomas-clinical-manifestations-diagnosis-and-staging-of-systemic-lymphoma\" class=\"medical medical_review\">AIDS-related lymphomas: Clinical manifestations, diagnosis, and staging of systemic lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-lymphomas-primary-effusion-lymphoma\" class=\"medical medical_review\">AIDS-related lymphomas: Primary effusion lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=aids-related-lymphomas-treatment-of-systemic-lymphoma\" class=\"medical medical_review\">AIDS-related lymphomas: Treatment of systemic lymphoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=bacterial-pulmonary-infections-in-hiv-infected-patients\" class=\"medical medical_review\">Bacterial pulmonary infections in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiac-and-vascular-disease-in-hiv-infected-patients\" class=\"medical medical_review\">Cardiac and vascular disease in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-acute-subacute-paracoccidioidomycosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of acute/subacute paracoccidioidomycosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-nocardiosis\" class=\"medical medical_review\">Clinical manifestations and diagnosis of nocardiosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-presentation-and-diagnosis-of-pneumocystis-pulmonary-infection-in-hiv-infected-patients\" class=\"medical medical_review\">Clinical presentation and diagnosis of Pneumocystis pulmonary infection in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cryptococcus-neoformans-infection-outside-the-central-nervous-system\" class=\"medical medical_review\">Cryptococcus neoformans infection outside the central nervous system</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnosis-and-treatment-of-disseminated-histoplasmosis-in-hiv-uninfected-patients\" class=\"medical medical_review\">Diagnosis and treatment of disseminated histoplasmosis in HIV-uninfected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-a-pleural-effusion-in-adults-initial-testing\" class=\"medical medical_review\">Diagnostic evaluation of a pleural effusion in adults: Initial testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-evaluation-of-pleural-effusion-in-adults-additional-tests-for-undetermined-etiology\" class=\"medical medical_review\">Diagnostic evaluation of pleural effusion in adults: Additional tests for undetermined etiology</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=etiology-clinical-presentation-and-diagnosis-of-chylothorax\" class=\"medical medical_review\">Etiology, clinical presentation, and diagnosis of chylothorax</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiv-infection-and-malignancy-epidemiology-and-pathogenesis\" class=\"medical medical_review\">HIV infection and malignancy: Epidemiology and pathogenesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hiv-infection-and-malignancy-management-considerations\" class=\"medical medical_review\">HIV infection and malignancy: Management considerations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immune-reconstitution-inflammatory-syndrome\" class=\"medical medical_review\">Immune reconstitution inflammatory syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphatic-filariasis-epidemiology-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Lymphatic filariasis: Epidemiology, clinical manifestations, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lymphatic-filariasis-treatment-and-prevention\" class=\"medical medical_review\">Lymphatic filariasis: Treatment and prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-malignant-pleural-effusions\" class=\"medical medical_review\">Management of malignant pleural effusions</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=multicentric-castlemans-disease\" class=\"medical medical_review\">Multicentric Castleman's disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=parapneumonic-effusion-and-empyema-in-adults\" class=\"medical medical_review\">Parapneumonic effusion and empyema in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pulmonary-involvement-in-aids-related-kaposi-sarcoma\" class=\"medical medical_review\">Pulmonary involvement in AIDS-related Kaposi sarcoma</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=toxoplasmosis-in-hiv-infected-patients\" class=\"medical medical_review\">Toxoplasmosis in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-and-prevention-of-pneumocystis-infection-in-hiv-infected-patients\" class=\"medical medical_review\">Treatment and prevention of Pneumocystis infection in HIV-infected patients</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-nocardiosis\" class=\"medical medical_review\">Treatment of nocardiosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-pulmonary-tuberculosis-in-hiv-infected-adults-initiation-of-therapy\" class=\"medical medical_review\">Treatment of pulmonary tuberculosis in HIV-infected adults: Initiation of therapy</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tuberculous-pleural-effusion\" class=\"medical medical_review\">Tuberculous pleural effusion</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=ultrasound-guided-thoracentesis\" class=\"medical medical_review\">Ultrasound-guided thoracentesis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=visceral-leishmaniasis-clinical-manifestations-and-diagnosis\" class=\"medical medical_review\">Visceral leishmaniasis: Clinical manifestations and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=visceral-leishmaniasis-epidemiology-and-control\" class=\"medical medical_review\">Visceral leishmaniasis: Epidemiology and control</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=visceral-leishmaniasis-treatment\" class=\"medical medical_review\">Visceral leishmaniasis: Treatment</a></li></ul></div></div>","javascript":null}